Heparan sulfate biosynthesis and sulfation profiles as modulators of cancer signalling and progression

C Marques, CA Reis, RR Vivès, A Magalhães - Frontiers in oncology, 2021 - frontiersin.org
Heparan Sulfate Proteoglycans (HSPGs) are important cell surface and Extracellular Matrix
(ECM) maestros involved in the orchestration of multiple cellular events in physiology and …

Glycosaminoglycans: Carriers and targets for tailored anti-cancer therapy

A Berdiaki, M Neagu, EM Giatagana, A Kuskov… - Biomolecules, 2021 - mdpi.com
The tumor microenvironment (TME) is composed of cancerous, non-cancerous, stromal, and
immune cells that are surrounded by the components of the extracellular matrix (ECM) …

Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma

J Zhang, JY Huang, YN Chen, F Yuan, H Zhang… - Scientific reports, 2015 - nature.com
Gastric cancer is one of the most aggressive cancers and is the second leading cause of
cancer death worldwide. Approximately 40% of global gastric cancer cases occur in China …

[HTML][HTML] NY-ESO-1 (CTAG1B) expression in mesenchymal tumors

M Endo, MA De Graaff, DR Ingram, S Lim, DC Lev… - Modern Pathology, 2015 - Elsevier
New York esophageal squamous cell carcinoma 1 (NY-ESO-1, CTAG1B) is a cancer-testis
antigen and currently a focus of several targeted immunotherapeutic strategies. We …

Cooperative effect of miR-141-3p and miR-145-5p in the regulation of targets in clear cell renal cell carcinoma

J Liep, E Kilic, HA Meyer, J Busch, K Jung, A Rabien - PloS one, 2016 - journals.plos.org
Background Due to the poor prognosis for advanced renal cell carcinoma (RCC), there is an
urgent need for new therapeutic targets and for prognostic markers to identify high risk …

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy

YX Zhang, JG van Oosterwijk, E Sicinska, S Moss… - Clinical Cancer …, 2013 - AACR
Purpose: Chondrosarcomas are notoriously resistant to cytotoxic chemotherapeutic agents.
We sought to identify critical signaling pathways that contribute to their survival and …

IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

AHG Cleven, J Suijker, G Agrogiannis… - Clinical Sarcoma …, 2017 - Springer
Background Mutations in isocitrate dehydrogenase (IDH) 1 or-2 are found in~ 50% of
conventional central chondrosarcomas and in up to 87% of their assumed benign …

[HTML][HTML] Heparan sulfate proteoglycan synthesis is dysregulated in human osteoarthritic cartilage

A Chanalaris, H Clarke, SE Guimond, TL Vincent… - The American journal of …, 2019 - Elsevier
Osteoarthritis (OA) is a common degenerative joint disease, characterized by cartilage loss
and subchondral bone remodeling in response to abnormal mechanical load. Heparan …

Biological role of heparan sulfate in osteogenesis: A review

Z Xu, S Chen, D Feng, Y Liu, Q Wang, T Gao, Z Liu… - Carbohydrate …, 2021 - Elsevier
Heparan sulfate (HS) is extensively expressed in cells, for example, cell membrane and
extracellular matrix of most mammalian cells and tissues, playing a key role in the growth …

[HTML][HTML] Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer

Y Jin, J He, J Du, RX Zhang, HB Yao… - Oncology …, 2017 - spandidos-publications.com
The purpose of the present study was to investigate the clinical significance of the
expression of heparan sulfate 6‑O‑sulfotransferase 2 (HS6ST2) in gastric cancer (GC). The …